Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elevance Health, Inc.ELV · Entity 2934 | EVP &Chief Health Benefits Ofr | March 02, 2026 | March 04, 2026 |
| WELLS FARGO & COMPANY/MNWFC · Entity 2824 | Director | April 28, 2026 | April 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elevance Health, Inc.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,838 |
Ending reported balance
After 2026-03-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-02 · Tax withholding · Disposed 1,421 · Balance 30,518 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Row 2 · 2026-03-02 · Grant · Acquired 5,951 · Balance 36,469 F2: Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029. Row 3 · 2026-03-02 · Grant · Acquired 2,865 · Balance 39,334 F3: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026. Row 4 · 2026-03-03 · Tax withholding · Disposed 496 · Balance 38,838 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $294.07 · Expires 2036-03-02 | Direct | 23,512 |
Reported balance
After 2026-03-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-02 · Grant · Acquired 23,512 · Balance 23,512 F4: The option represents a right to purchase a total of 23,512 shares, and is exercisable in two installments of 7,837 shares each and one installment of 7,838 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029.
F3: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
F4: The option represents a right to purchase a total of 23,512 shares, and is exercisable in two installments of 7,837 shares each and one installment of 7,838 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.
WELLS FARGO & COMPANY/MN
Report date April 28, 2026 · Filed April 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,851.9647 |
Reported balance
After 2026-04-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-28 · Grant · Acquired 3,436 · Balance 17,851.9647 F1: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2: Each Common Stock Unit represents a right to receive one share of Company common stock. F3: Includes dividend equivalents reinvested in additional Common Stock Units. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | Direct | 5,384 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,384 |
| Preferred Shares, Series AASEC Table I · non-derivative | Direct | 152 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 152 |
| Preferred Shares, Series DDSEC Table I · non-derivative | Direct | 247 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 247 |
| Preferred Shares, Series LSEC Table I · non-derivative | Direct | 11 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 11 |
| Preferred Shares, Series ZSEC Table I · non-derivative | Direct | 228 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 228 |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director.
F2: Each Common Stock Unit represents a right to receive one share of Company common stock.
F3: Includes dividend equivalents reinvested in additional Common Stock Units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hill-Rom Holdings, Inc.
Report date December 13, 2021 · Filed December 15, 2021
Section 16 reporting ended · disclosed 2021-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (02/26/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-13 · Disposition to issuer · Disposed 1,870 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/11/2021)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-13 · Disposition to issuer · Disposed 1,798 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2021-12-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2026 Filed Apr 30, 2026 21:14 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 3,436 | $81.50 | $280,034.00 |
DisclosureSEC source: 0000072971-26-000243 · form4.xml · derivative · entry 6 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,851.9647 Underlying: Common Stock, $1 2/3 Par Value · 3,436 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F3 · balance_after: Includes dividend equivalents reinvested in additional Common Stock Units. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:58 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 496 | $284.03 | $140,878.88 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,838 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:58 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 23,512 | $0.00 Strike: $294.07 | $0.00 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · derivative · entry 5 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,512 Underlying: Common Stock · 23,512 shares Expires 2036-03-02 F4 · derivative.exercise_date: The option represents a right to purchase a total of 23,512 shares, and is exercisable in two installments of 7,837 shares each and one installment of 7,838 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:58 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 2,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,334 F3 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:58 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 5,951 | $0.00 | $0.00 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,469 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:58 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 1,421 | $294.07 | $417,873.47 |
DisclosureSEC source: 0001743548-26-000002 · wk-form4_1772661524.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP &Chief Health Benefits Ofr 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,518 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| April 29, 2025 Filed May 1, 2025 21:32 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 3,728 | $71.10 | $265,060.80 |
DisclosureSEC source: 0001127602-25-013000 · form4.xml · derivative · entry 6 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,108.4723 Underlying: Common Stock, $1 2/3 Par Value · 3,728 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F3 · balance_after: Includes dividend equivalents reinvested in additional Common Stock Units. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:50 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,549 | $0.00 Strike: $395.50 | $0.00 |
DisclosureSEC source: 0001156039-25-000028 · wk-form4_1741211429.xml · derivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,549 Underlying: Common Stock · 11,549 shares Expires 2035-03-03 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,549 shares, and is exercisable in three annual installments, with one installment of 3,849 shares and two installments of 3,850 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:50 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 4,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-25-000028 · wk-form4_1741211429.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,939 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/3/2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:50 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 3,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-25-000028 · wk-form4_1741211429.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,726 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,011 shares on 3/3/2026, and 1,012 shares each on 3/3/2027 and 3/3/2028. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:50 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 2,613 | $395.50 | $1,033,441.50 |
DisclosureSEC source: 0001156039-25-000028 · wk-form4_1741211429.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,691 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:51 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 4,046 | $59.32 | $240,008.72 |
DisclosureSEC source: 0001127602-24-014012 · form4.xml · derivative · entry 6 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,106.1884 Underlying: Common Stock, $1 2/3 Par Value · 4,046 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. Read SEC document |
| April 24, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,043 | $0.00 Strike: $238.27 | $0.00 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · derivative · entry 8 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,043 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| April 24, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | SaleCommon Stock | 3,434 | $532.68 | $1,829,223.12 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 6 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,304 F3 · price: This transaction was executed in multiple trades at prices ranging from $532.44 to $533.30. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 24, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | SaleCommon Stock | 2,765 | $532.14 | $1,471,367.10 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 5 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,738 F2 · price: This transaction was executed in multiple trades at prices ranging from $531.44 to $532.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 24, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | Exercise / conversionCommon Stock | 2,043 | $238.27 | $486,785.61 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,473 | $0.00 Strike: $238.27 | $0.00 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · derivative · entry 7 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,043 Underlying: Common Stock · 5,473 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | SaleCommon Stock | 100 | $534.74 | $53,474.00 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,460 Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | SaleCommon Stock | 14,011 | $533.73 | $7,478,091.03 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,560 F1 · price: This transaction was executed in multiple trades at prices ranging from $533.60 to $534.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 23, 2024 Filed Apr 25, 2024 21:05 UTC | Elevance Health, Inc. ELV · Entity 2934 | Exercise / conversionCommon Stock | 5,473 | $238.27 | $1,304,051.71 |
DisclosureSEC source: 0001415889-24-011527 · form4-04252024_090423.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:51 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | OtherPreferred Shares, Series R | 118 | $25.00 | $2,950.00 |
DisclosureSEC source: 0001415889-24-008571 · form4-03192024_080353.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Depository shares, each representing a 1/1,000th interest in a share of Wells Fargo & Company 6.625% Fixed-to-Floating Rate Non-Cumulative Perpetual Class A Preferred Stock, Series R, were called for redemption by the issuer at a price equal to their face value. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,280 | $0.00 Strike: $499.11 | $0.00 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · derivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,280 Underlying: Common Stock · 9,280 shares Expires 2034-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 9,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,098 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 2,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,946 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:25 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 4,902 | $499.11 | $2,446,637.22 |
DisclosureSEC source: 0001156039-24-000030 · wk-form4_1709673934.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President,Gov Health Ben 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,541 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 20:39 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | OtherPreferred Shares, Series Q | 498 | $25.00 | $12,450.00 |
DisclosureSEC source: 0001127602-23-024442 · form4.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Depositary shares, each representing a 1/1,000th interest in a share of Wells Fargo & Company 5.85% Fixed-to-Floating Rate Non-Cumulative Perpetual Class A Preferred Stock, Series Q, were called for redemption by the issuer at a price equal to their face value. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 22:23 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 5,919 | $40.55 | $240,015.45 |
DisclosureSEC source: 0001127602-23-013693 · form4.xml · derivative · entry 9 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,919 Underlying: Common Stock, $1 2/3 Par Value · 5,919 shares Expires not disclosed F6 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F7 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F6 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F6 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. Read SEC document |
| March 16, 2023 Filed Apr 27, 2023 22:23 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | PurchasePreferred Shares, Series Z | 77 | $18.85 | $1,451.14 |
DisclosureSEC source: 0001127602-23-013693 · form4.xml · nonDerivative · entry 5 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228 F5 · kind: The Reporting Person did not have a non-exempt sale of the relevant securities for purposes of Section 16 of the Exchange Act six months before this purchase. F4 · balance_after: Includes 8 shares not previously reported on the Form 3 filed by the Reporting Person on April 28, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:24 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 4,754 | $468.78 | $2,228,580.12 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,443 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,812 | $0.00 Strike: $469.03 | $0.00 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · derivative · entry 5 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,812 Underlying: Common Stock · 8,812 shares Expires 2033-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 9,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,197 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC | Elevance Health, Inc. ELV · Entity 2934 | GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,481 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:24 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 495 | $469.03 | $232,169.85 |
DisclosureSEC source: 0001156039-23-000029 · wf-form4_167787862440989.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,189 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 21:50 UTC | Elevance Health, Inc. ELV · Entity 2934 | Tax withholdingCommon Stock | 1,754 | $512.97 | $899,749.38 |
DisclosureSEC source: 0001156039-23-000002 · wf-form4_167286901422962.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,684 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| October 18, 2022 Filed Apr 27, 2023 22:23 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | PurchasePreferred Shares, Series Z | 6 | $18.00 | $107.98 |
DisclosureSEC source: 0001127602-23-013693 · form4.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151 F1 · kind: The Reporting Person did not have a non-exempt sale of the relevant securities for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") six months before or after this purchase. F4 · balance_after: Includes 8 shares not previously reported on the Form 3 filed by the Reporting Person on April 28, 2022. Read SEC document |
| October 18, 2022 Filed Apr 27, 2023 22:23 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | PurchasePreferred Shares, Series AA | 5 | $17.84 | $89.20 |
DisclosureSEC source: 0001127602-23-013693 · form4.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152 F1 · kind: The Reporting Person did not have a non-exempt sale of the relevant securities for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") six months before or after this purchase. F3 · balance_after: Includes 9 shares not previously reported on the Form 3 filed by the Reporting Person on April 28, 2022. Read SEC document |
| August 01, 2022 Filed Apr 27, 2023 22:23 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | PurchasePreferred Shares, Series L | 1 | $1,276.63 | $1,276.63 |
DisclosureSEC source: 0001127602-23-013693 · form4.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11 F1 · kind: The Reporting Person did not have a non-exempt sale of the relevant securities for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") six months before or after this purchase. Read SEC document |
| August 01, 2022 Filed Apr 27, 2023 22:23 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | PurchasePreferred Shares, Series DD | 9 | $18.93 | $170.36 |
DisclosureSEC source: 0001127602-23-013693 · form4.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247 F1 · kind: The Reporting Person did not have a non-exempt sale of the relevant securities for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") six months before or after this purchase. F2 · balance_after: Includes 13 shares not previously reported on the Form 3 filed by the Reporting Person on April 28, 2022. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 17:15 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock, $1 2/3 Par Value | 5,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012654 · form4.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,384 Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 446 | $463.49 | $206,716.54 |
DisclosureSEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,438 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,832 | $0.00 Strike: $451.50 | $0.00 |
DisclosureSEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · derivative · entry 5 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,832 Underlying: Common Stock · 8,832 shares Expires 2032-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 8,832 shares, and is exercisable in three annual installments of 2,944 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 6,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 3 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,884 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 2 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,903 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 738 shares each on 3/1/2023 and 3/1/2024, and 739 shares on 3/1/2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 3,568 | $451.50 | $1,610,952.00 |
DisclosureSEC source: 0001156039-22-000019 · wf-form4_164634369986340.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,688 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 1,754 | $467.15 | $819,381.10 |
DisclosureSEC source: 0001156039-22-000004 · wf-form4_164133190194460.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,256 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (03/11/2021) · Derivative | 1,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013214 · marketforms-54641.xml · derivative · entry 3 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,798 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2 · price: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.exercise_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.expiration_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (02/26/2020) · Derivative | 1,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013214 · marketforms-54641.xml · derivative · entry 2 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,870 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2 · price: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.exercise_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.expiration_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 5,543 | $387.20 | $2,146,249.60 |
DisclosureSEC source: 0001156039-21-000072 · wf-form4_162568982597252.xml · nonDerivative · entry 1 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,010 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 16:03 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantNon-Employee Restricted Stock Units (Deferred Stock Award) · Derivative | 1,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-21-000031 · wf-form4_161558300826553.xml · derivative · entry 2 Norwood Felicia F · CIK 0001743548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 1,787 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · kind: Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 296 | $311.66 | $92,251.36 |
DisclosureSEC source: 0001156039-21-000024 · wf-form4_161480708330602.xml · nonDerivative · entry 4 Norwood Felicia F · CIK 0001743548 · EVP & President, GBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,553 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.